Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...

Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...

Gilead’s short-term win could come at massive cost to the future of pharmaceutical innovation and to the health of the American public. The U.S. government filed the lawsuit in 2019, alleging ...

putting untold numbers of patients' health and safety at risk," the lawsuit, filed by attorney Geoffrey Potter of Patterson ...

OAKLAND, Calif. (CN) — The biopharmaceutical drug giant Gilead Sciences Inc. must face claims in a federal lawsuit that the company sold defective drugs to people living with HIV and AIDS, a judge ...

California-based Gilead also faces another lawsuit that it illegally delayed its next generation of HIV meds to maximise revenues from its older drugs before they went off-patent. The company also ...

In these lawsuits, the plaintiffs allege Gilead Sciences failed to inform consumers about the potential risks or side effects of their HIV medication. Additionally, the lawsuits also claim the ...

Gilead has won another victory in a wide-ranging lawsuit brought against clinics, prescribers, medical labs, and pharmacies it has accused of making fraudulent reimbursement claims for HIV medicines.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...